Publications of Mira Dalal
All genres
Journal Article (17)
1.
Journal Article
152 (1), pp. 255 - 260 (2014)
Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature. SCHIZOPHRENIA RESEARCH 2.
Journal Article
135 (1-3), pp. 123 - 127 (2012)
Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research 3.
Journal Article
35 (2), pp. 231 - 236 (2012)
Glucose Tolerance in Patients with Narcolepsy. Sleep 4.
Journal Article
34 (1), pp. 118 - 128 (2009)
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 5.
Journal Article
17 (Suppl. 1), p. 201 - 201 (2008)
What does paroxetine do with sleep? Its effects in mdr 1a/1b (-/-) and fvb wild-type mice. Journal of Sleep Research 6.
Journal Article
27 (6), pp. 662 - 666 (2007)
Clozapine and olanzapine are associated with food craving and binge eating - Results from a randomized double-blind study. Journal of Clinical Psychopharmacology 7.
Journal Article
40 (5), p. 241 - 241 (2007)
Daytime sleep after glucose intake in patients with narcolepsy. Pharmacopsychiatry 8.
Journal Article
34 (2), pp. 93 - 94 (2007)
Gabapentin bei einer Patientin mit Panikstörung und Unverträglichkeit von Carbamazepin während des Benzodiazepinentzugs. Psychiatrische Praxis 9.
Journal Article
2, pp. 293 - 302 (2007)
Immunoendocrine abnormalities in narcolepsy. Sleep Medicine Clinics 10.
Journal Article
114, pp. 322 - 328 (2006)
Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Experimental and Clinical Endocrinology & Diabetes 11.
Journal Article
38 (5), p. 230 - 230 (2005)
Impaired glucose tolerance in patients with narcolepsy. Pharmacopsychiatry 12.
Journal Article
286 (6), pp. E963 - E967 (2004)
Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. American Journal of Physiology-Endocrinology and Metabolism 13.
Journal Article
36 (5), p. 218 - 218 (2003)
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Pharmacopsychiatry 14.
Journal Article
36 (5), pp. 263 - 264 (2003)
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects - First results from a double-blind, placebocontrolled study. Pharmacopsychiatry 15.
Journal Article
8, pp. 836 - 837 (2003)
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Molecular Psychiatry 16.
Journal Article
11 (3), p. 273 - 273 (2002)
Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy. Journal of Sleep Research 17.
Journal Article
56, pp. 1749 - 1751 (2001)
Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology Book Chapter (1)
18.
Book Chapter
Leptin and psychopharmacology. In: Psychoneuroimmunology. Hypotheses and Current Research. Advances in Biological Psychiatry, Vol. 20, pp. 20 - 29 (Eds. Sperner-Unterweger, B.; Fleischhacker, W.; Kaschka, W.). Karger, Basel (2001)